A recent Norwegian study on aspirin and colon cancer patients was published in May. Unlike many other, smaller studies, they were able to survey the entire population and had automatically recorded their aspirin use from over ten years ago. Bad for personal privacy, good for medical research.
The study combined all cancer groups, but found a significant (15%) reduction in cancer deaths directly associated with aspirin use. Stage II patients benefitted slightly more.
Aspirin is recommended in my book, The Colon Cancer Diet, though my personal experience with it has been that it likely increased my CEA. It’s nice to see it being supported so broadly.
A study of this size is wonderful because it doesn’t just make the alternative medical journals. Not only did the study get written up by N.D.s (article here), it appears on a conservative Texas Colon Cancer Research Center’s site.
Hopefully, the broad interest will translate into a changing of recommendations for colon cancer patients. The problem is that adding aspirin after surgery might make surgeons concerned about bleeding. So the proper time to recommend aspirin would be at the six week follow-up appointment.